Initial Clinical Experience with Intensity-Modulated Whole-Pelvis Radiation Therapy in Women with Gynecologic Malignancies

By Mundt A.J.   Roeske J.C.   Lujan A.E.   Yamada S.D.   Waggoner S.E.   Fleming G.   Rotmensch J.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 456-463

Elsevier

Access to resources Recommend Favorite

Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 601-606

Science Publishers

Access to resources Recommend Favorite

Clinical Predictors of Severe Toxicity in Patients Treated with Combination Chemotherapy with Irinotecan and/or Oxaliplatin for Metastatic Colorectal Cancer: A Single Center Experience

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 347-358

Humana Press, Inc

Access to resources Recommend Favorite

Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: A clinical experience

By Subbarayan Pochi R.   Lima Mayra   Ardalan Bach  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 557-561

Informa Healthcare

Access to resources Recommend Favorite

Clinical observation of gefitinib as a first-line therapy in sixty-eight patients with advanced NSCLC

By            

Oncology Letters, Vol. 3, Iss. 5, 2012-01 ,pp. : 1064-1068

Spandidos Publications

Access to resources Recommend Favorite